Investors Press Releases Cardiol Therapeutics’ Cortalex™ CBD Now Available Exclusively Online at Medical Cannabis by Shoppers Inc. October 20, 2020 Cardiol Therapeutics Receives FDA Approval for Investigational New Drug (IND) Application for Phase II/III COVID-19 Trial September 25, 2020 Cardiol Therapeutics to Present at the H.C. Wainwright Virtual 22nd Annual Global Investment Conference September 15, 2020 Cardiol Therapeutics Initiates Health Canada Approved Phase 1 Clinical Study of CardiolRx™ August 26, 2020 Cardiol Therapeutics Appoints CNBC Market Analyst Steven Grasso as Business Advisor June 29, 2020 David Elsley Files Early Warning Report for Cardiol Therapeutics June 25, 2020 Cardiol Therapeutics Closes $17.25 Million Bought Deal Offering, Including Full Exercise of the Over-Allotment Option June 04, 2020 Cardiol Therapeutics Reports 2020 AGM Results June 02, 2020 Cardiol Therapeutics to Webcast Virtual Annual General Meeting on June 1st at 4:30 p.m. EDT May 29, 2020 Cardiol Therapeutics Announces Increase to Previously Announced Bought Deal Public Offering May 14, 2020 Page 1 of 612345...»Last »
